The GI-MAP includes the first comprehensive pathogens assay that is FDA approved, the GPP assay by Luminex Corp. The pathogen targets include bacteria, parasites and another first for the market, viruses!

Using the same molecular technology, we have developed assays for microbes that are useful for integrative and function medicine practitioners. And unlike previous PCR assays, we have fully validated each target organism in our panel, so that you can have confidence in the results. The panel includes opportunistic organisms, normal flora, parasites, and fungi. DNA/PCR techniques also allow for the measurement of antibiotic resistance genes and virulence factors that contribute to pathogenicity. Both are used to help determine clinical significance and the most effective treatments.

Other available stool tests may appear to be DNA-based tests, but they are in fact using Matrix Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) only to identify stool microbes. Their methodology relies on cultures from stool and are not molecular/PCR based assays. With a culture based test it is not possible to measure strict anaerobes, viruses or virulence factors. They also lack the ability to deliver true quantitation of any of the reported organisms.